Aytu BioPharma Statistics Share Statistics Aytu BioPharma has 6.17M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 6.17M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) 30.59% Shares Floating n/a Failed to Deliver (FTD) Shares 30,327 FTD / Avg. Volume 10.18%
Short Selling Information The latest short interest is 470.77K, so 5.24% of the outstanding
shares have been sold short.
Short Interest 470.77K Short % of Shares Out 5.24% Short % of Float 6.64% Short Ratio (days to cover) 3.86
Valuation Ratios The PE ratio is -1 and the forward
PE ratio is -3.1.
Aytu BioPharma's PEG ratio is
0.02.
PE Ratio -1 Forward PE -3.1 PS Ratio 0.19 Forward PS 0.2 PB Ratio 0.57 P/FCF Ratio -11.37 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Aytu BioPharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.99,
with a Debt / Equity ratio of 0.59.
Current Ratio 0.99 Quick Ratio 0.79 Debt / Equity 0.59 Debt / EBITDA -16.22 Debt / FCF -11.83 Interest Coverage -1.1
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $794.14K Profits Per Employee $-155.33K Employee Count 102 Asset Turnover 0.69 Inventory Turnover 2.5
Taxes Income Tax 1.77M Effective Tax Rate -12.56%
Stock Price Statistics The stock price has increased by -5.44% in the
last 52 weeks. The beta is 0.23, so Aytu BioPharma's
price volatility has been higher than the market average.
Beta 0.23 52-Week Price Change -5.44% 50-Day Moving Average 2.33 200-Day Moving Average 1.71 Relative Strength Index (RSI) 45.9 Average Volume (20 Days) 298,020
Income Statement In the last 12 months, Aytu BioPharma had revenue of 81M
and earned -15.84M
in profits. Earnings per share was -2.86.
Revenue 81M Gross Profit 49.37M Operating Income -5.25M Net Income -15.84M EBITDA -1.01M EBIT -9.28M Earnings Per Share (EPS) -2.86
Full Income Statement Balance Sheet The company has 20.01M in cash and 16.42M in
debt, giving a net cash position of 3.59M.
Cash & Cash Equivalents 20.01M Total Debt 16.42M Net Cash 3.59M Retained Earnings -319.97M Total Assets 124.2M Working Capital 1.81M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -1.39M
and capital expenditures 0, giving a free cash flow of -1.39M.
Operating Cash Flow -1.39M Capital Expenditures n/a Free Cash Flow -1.39M FCF Per Share -0.25
Full Cash Flow Statement Margins Gross margin is 60.95%, with operating and profit margins of -6.49% and -19.56%.
Gross Margin 60.95% Operating Margin -6.49% Pretax Margin -17.38% Profit Margin -19.56% EBITDA Margin -1.25% EBIT Margin -6.49% FCF Margin -1.71%
Dividends & Yields AYTU does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for AYTU is $10,
which is 342.5% higher than the current price. The consensus rating is "Buy".
Price Target $10 Price Target Difference 342.5% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 6, 2023. It was a
backward
split with a ratio of 1:20.
Last Split Date Jan 6, 2023 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -2.84 Piotroski F-Score 3
